RS

Rohit Singhal

Director Director DIN 07539155
DIN 07539155 First appointment Jul 2016 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Rohit Singhal

Data last updated:

Rohit Singhal was a Director at Vedaka Cyber Private Limited (2016) and Director at Bioplx Microbiomics Private Limited (2016). The companies operate in Information Technology and Pharma.

DIN 07539155
Primary Designation Director
Industry Information Technology
First Appointment 19 Jul 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vedaka Cyber Private Limited U72900UP2016FTC084992
Director19 Jul 20162016Strike Off
Bioplx Microbiomics Private Limited U73200UP2016FTC086076
Director01 Sep 20162016Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vedaka Cyber Private Limited
Bioplx Microbiomics Private Limited
Premium access

Shareholding and investment profile for Rohit Singhal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohit Singhal

Rohit Singhal was first appointed on 19 Jul 2016 as Director at Vedaka Cyber Private Limited.

Rohit Singhal held 2 earlier board appointments: Vedaka Cyber Private Limited (Director, 19 Jul 2016 to 13 Oct 2016); Bioplx Microbiomics Private Limited (Director, 01 Sep 2016 to 13 Oct 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available